tert-butyl (4-chloropyrimidin-2-yl)(methyl)carbamate

Catalog No. :
ACFQVG825
CAS No. :
1240594-10-8
Molecular Formula :
C10H14ClN3O2
Molecular Weight :
243.69

IUPAC Name:tert-butyl (4-chloropyrimidin-2-yl)(methyl)carbamate

tert-butyl (4-chloropyrimidin-2-yl)(methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$288.00Login to see priceInquiryInquiry
250mg95%$462.00Login to see priceInquiryInquiry
1g95%$1151.00Login to see priceInquiryInquiry
5g95%$3456.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl (4-chloropyrimidin-2-yl)(methyl)carbamate
IUPAC Nametert-butyl (4-chloropyrimidin-2-yl)(methyl)carbamate
MDL No.MFCD13195451
Molecular FormulaC10H14ClN3O2
Molecular Weight243.69
SMILESO=C(OC(C)(C)C)N(C1=NC=CC(Cl)=N1)C
InChI KeyZUFKXEMZBDDGCR-UHFFFAOYSA-N
Synonymtert-butyl (4-chloropyrimidin-2-yl)methylcarbamate;Carbamic acid, N-[(4-chloro-2-pyrimidinyl)methyl]-, 1,1-dimethylethyl ester
CAS No.1240594-10-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFQVG825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFQVG825 route product structure diagram
    ACFQVG8251240594-10-8
Inquiry

2. ACFQVG825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSRMQ874 route compound structure diagram
    ACSRMQ87416066-84-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFQVG825 route product structure diagram
    ACFQVG8251240594-10-8
Inquiry

Comments (0)